Semtech’s LoRa wireless technology used to monitor skiing students in Swiss Alps
Camarillo-based Semtech has announced that, after a successful trial, a ski tracker using its LoRa wireless technology will be used to monitor skiing students on the slopes of the Swiss Alps in the upcoming 2016-2017 ski season. A LoRaWAN low power, wide area network, comprised of base stations and sensors embedded with Semtech LoRa technology, Read More →
Read More →American Riviera Bank’s second quarter net income up
Santa Barbara-based American Riviera Bank reported net income of $1.425 million, or 33 cents per share, for the second quarter of 2016. That was up from $362,000, or 13 cents per share, over the same period last year. The bank finalized its merger with The Bank of Santa Barbara earlier this year. “We are very Read More →
Read More →Citizens Business Bank second quarter net income down from 2015
CVB Financial Corp. and its subsidiary Citizens Business Bank reported $25.5 million net income for the second quarter of 2016, or 23 cents per share. That was down from $26.8 million for the second quarter of 2015, or 25 cents per share. Citizens Business Bank completed the integration of County Commerce Bank in the second Read More →
Read More →Lockheed Martin second quarter earnings beat analyst estimates
Lockheed Martin revenues increased slightly and the company beat analyst estimates when it reported second quarter earnings results July 19. Lockheed Martin said sales increased during the quarter from $11.6 billion during the same quarter in 2015 to $12.9 billion in 2016. Earnings per share increased from $2.94 to $3.32 per share over the same Read More →
Read More →Ceres third-quarter revenue up, losses down
Thousand Oaks-based ag-biotech company Ceres Inc. released third quarter results in documents filed with the Securities and Exchange Commission July 15. Ceres said revenues increased from $1.1 million during the third quarter of 2015 to $1.4 million during the third quarter of 2016. Net losses decreased from $5.9 million, or 98 cents per share, last Read More →
Read More →FDA finds Amgen biosimilar replicates effects of Humira
The Food and Drug Administration said a new Amgen biosimilar replicates the effects of a competitor’s blockbuster drug July 8. ABP 501 replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. The drug, made by Chicago-based competitor AbbVie, typically costs $20,000 per year for Read More →
Read More →Stellar Biotechnologies offerings raise $6.75 million
Stellar Biotechnologies, a Port Hueneme-based company which makes medicines from the blood of animals found only off the coast of California, closed two private offerings July 6. Stellar closed one offering of 1.7 million common shares sold to institutional investors for $4 per share. In a separate concurrent offering, the company also sold 1.3 million Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
